BioPharma
CDMO-Biotech Collab Diminish Business Risk In Drug Creation
Biotech companies go on to face numerous challenges, particularly while in the clinical phase of drug development, in today's fast-paced industry. The astronomically high costs,...
Drug Research
Vetter Further Invests €230M in New Production Building
Vetter, a global CDMO, is making additional investments as part of its long-lead goals for continued expansion and to support customer needs. The company is investing...
Drug Research
Lonza to enhance commercial antibody-drug conjugate supply capacity
Lonza is planning to build a commercial-scale aseptic current good manufacturing practice (cGMP) filling line at its site in Stein, Switzerland. The new filling line...
Drug Research
Gritgen Therapeutics Launches Commercial GMP Facility in China
Gritgen Therapeutics Co., a biotechnology company focused on gene therapy products, reported the successful validation and launch of operations at its commercial GMP facility in...
Drug Research
Cellipont and Diakonos to develop cell therapy for glioblastoma
Cellipont Bioservices has signed an agreement with Diakonos Oncology for the development of DOC1021, a cell therapy to treat glioblastoma multiforme (GBM).
The parties will carry...
Drug Research
Sygnature Discovery collaborates with Axol Bioscience to utilize human iPSC-derived microglial cells in high-content imaging drug discovery screening workflows
Sygnature Discovery, a world-leading integrated drug discovery provider and non-clinical solutions provider, has announced a scientific collaboration with human induced pluripotent stem cell (iPSC) experts,...
Drug Research
BioCity, AstraZeneca Partner on Treatment of Advanced HCC
BioCity Biopharma and AstraZeneca signed an agreement to collaborate on a Phase Ib/II clinical study to evaluate the safety and efficacy of BioCity's BC3402, a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.